MAXY 735
Latest Information Update: 07 Jun 2013
At a glance
- Originator Maxygen
- Class Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 07 Jun 2013 Discontinued - Preclinical for Autoimmune disorders in USA (unspecified route)
- 09 Jun 2006 No development reported - Preclinical for Autoimmune disorders in USA (unspecified route)
- 31 Oct 2003 Preclinical trials in Autoimmune disorders in USA (unspecified route)